# A Feasibility Study of Advance Plasma Therapy001 Plasma/Nitric Oxide Therapy for the Treatment of Diabetic Foot Ulcers

> **NCT03078933** · NA · UNKNOWN · sponsor: **Origin Inc.** · enrollment: 100 (estimated)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **DEVICE:** Standard of Care
- **DEVICE:** Nitric Oxide Therapy 2x week 6 min. plus standard of care
- **DEVICE:** Nitric Oxide Therapy 2x week 12 min. plus standard of care
- **DEVICE:** Nitric Oxide Therapy 4x week 6 min. plus standard of care
- **DEVICE:** Nitric Oxide Therapy 4x week 12 min. plus standard of care

## Key facts

- **NCT ID:** NCT03078933
- **Lead sponsor:** Origin Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-03-20
- **Primary completion:** 2018-05
- **Final completion:** 2018-07
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2017-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03078933

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03078933, "A Feasibility Study of Advance Plasma Therapy001 Plasma/Nitric Oxide Therapy for the Treatment of Diabetic Foot Ulcers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03078933. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*